These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34479796)

  • 21. Cardiovascular risk factors and metabolic control in type 2 diabetic subjects attending outpatient clinics in Italy: the SFIDA (survey of risk factors in Italian diabetic subjects by AMD) study.
    Comaschi M; Coscelli C; Cucinotta D; Malini P; Manzato E; Nicolucci A;
    Nutr Metab Cardiovasc Dis; 2005 Jun; 15(3):204-11. PubMed ID: 15955469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simultaneous control of blood glucose, blood pressure, and lipid among drug-treated Type 2 diabetes patients from Shaanxi province, North-Western China: A multicenter study.
    Xu S; Sun F; Xu W; Jiao K; Shi B; Xie X; Wang Y; Zhu M; Ji Q
    Niger J Clin Pract; 2016; 19(6):784-792. PubMed ID: 27811452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors Associated with Poor Glycemic and Lipid Levels in Ambulatory Diabetes Mellitus Type 2 Patients in Asmara, Eritrea: A Cross-Sectional Study.
    Achila OO; Ghebretinsae M; Kidane A; Simon M; Makonen S; Rezene Y
    J Diabetes Res; 2020; 2020():5901569. PubMed ID: 32090121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Control of cardiovascular risk factors in patients with diabetes and hypertension at urban academic medical centers.
    McFarlane SI; Jacober SJ; Winer N; Kaur J; Castro JP; Wui MA; Gliwa A; Von Gizycki H; Sowers JR
    Diabetes Care; 2002 Apr; 25(4):718-23. PubMed ID: 11919131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and risk factors of diabetic retinopathy in subjects with suboptimal glycemic, blood pressure and lipid control. Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS, Report 33).
    Raman R; Gupta A; Kulothungan V; Sharma T
    Curr Eye Res; 2012 Jun; 37(6):513-23. PubMed ID: 22577770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Achievement of national clinical practice recommendations among those in the Puerto Rican population with diabetes mellitus.
    Rodríguez-Vigil E; Rodríguez-Chacón M; Trabanco C; Irizarry-Ramos J
    P R Health Sci J; 2014 Dec; 33(4):157-62. PubMed ID: 25563032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of 33 488 children and adolescents with type 1 diabetes based on the gender-specific increase of cardiovascular risk factors.
    Schwab KO; Doerfer J; Marg W; Schober E; Holl RW;
    Pediatr Diabetes; 2010 Aug; 11(5):357-63. PubMed ID: 20624248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of LDL-hypercholesterolemia and other cardiovascular risk factors in young people with type 1 diabetes.
    Drozd I; Weiskorn J; Lange K; Biester T; Datz N; Kapitzke K; Reschke F; von dem Berge T; Weidemann J; Danne TPA; Kordonouri O
    J Clin Lipidol; 2023; 17(4):483-490. PubMed ID: 37258406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glycaemic, blood pressure and low-density lipoprotein-cholesterol control among patients with diabetes mellitus in a specialised clinic in Botswana: a cross-sectional study.
    Mwita JC; Francis JM; Omech B; Botsile E; Oyewo A; Mokgwathi M; Molefe-Baikai OJ; Godman B; Tshikuka JG
    BMJ Open; 2019 Jul; 9(7):e026807. PubMed ID: 31340960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primacy of the 3B approach to control risk factors for cardiovascular disease in type 2 diabetes patients.
    Ji L; Hu D; Pan C; Weng J; Huo Y; Ma C; Mu Y; Hao C; Ji Q; Ran X; Su B; Zhuo H; Fox KA; Weber M; Zhang D; ;
    Am J Med; 2013 Oct; 126(10):925.e11-22. PubMed ID: 23810406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Microalbuminuria Education Medication and Optimisation (MEMO) study: 4 years follow-up of multifactorial intervention in high-risk individuals with type 2 diabetes.
    Crasto W; Morrison AE; Gray LJ; John E; Jarvis J; Brela J; Khunti K; Troughton J; Lawrence IG; McNally PG; Davies MJ
    Diabet Med; 2020 Feb; 37(2):286-297. PubMed ID: 31505051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Control of diabetes and cardiovascular risk factors in patients with type 2 diabetes: a nationwide French survey.
    Charpentier G; Genès N; Vaur L; Amar J; Clerson P; Cambou JP; Guéret P;
    Diabetes Metab; 2003 Apr; 29(2 Pt 1):152-8. PubMed ID: 12746636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treating hypertension to reduce cardiovascular risk: a Korean perspective.
    Kim KI; Kim CH
    Clin Ther; 2012 Jul; 34(7):1559-68. PubMed ID: 22704810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diabetes control in type 2 diabetic subjects treated in primary health care--how far is from life to standards?].
    Fabian W; Majkowska L; Stefański A; Moleda P
    Przegl Lek; 2008; 65(6):277-82. PubMed ID: 18853658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood pressure and cholesterol control in hypertensive hypercholesterolemic patients: national health and nutrition examination surveys 1988-2010.
    Egan BM; Li J; Qanungo S; Wolfman TE
    Circulation; 2013 Jul; 128(1):29-41. PubMed ID: 23817481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cross-sectional epidemiological study of clinical profiles and glycemic control in diabetic patients in primary care in Spain (the EPIDIAP study)].
    de Pablos Velasco P; Franch J; Banegas Banegas JR; Fernández Anaya S; Sicras Mainar A; Díaz Cerezo S
    Endocrinol Nutr; 2009 May; 56(5):233-40. PubMed ID: 19627744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic control and chronic complications during a 3-year follow-up period in a cohort of type 2 diabetic patients attended in primary care in the Community of Madrid (Spain).
    Arrieta F; Piñera M; Iglesias P; Nogales P; Salinero-Fort MA; Abanades JC; Botella-Carretero JI; Calañas A; Balsa JA; Zamarrón I; Rovira A; Vázquez C;
    Endocrinol Nutr; 2014 Jan; 61(1):11-7. PubMed ID: 24182687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycaemic control and control of risk factors in diabetes patients in an ophthalmology clinic: what lessons have we learned from the UKPDS and DCCT studies?
    Higgins GT; Khan J; Pearce IA
    Acta Ophthalmol Scand; 2007 Nov; 85(7):772-6. PubMed ID: 17944626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evaluation and care of patients with type Ii diabetes regarding recommendations concerning cardiovascular risk factors and adherence to values in general medicine in the Grand Duchy of Luxembourg].
    Stein R; Aubart-Schuller M; Vandenberghe H
    Bull Soc Sci Med Grand Duche Luxemb; 2010; (2):289-301. PubMed ID: 20882748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adequacy of control of cardiovascular risk factors in ambulatory patients with type 2 diabetes attending diabetes out-patients clinic at a county hospital, Kenya.
    Kimando MW; Otieno FCF; Ogola EN; Mutai K
    BMC Endocr Disord; 2017 Dec; 17(1):73. PubMed ID: 29191193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.